Chapter 20 puberty and the menstrual cycle and menopause Flashcards

0
Q

Breast bud development to menstruation how many yrs?

A

2.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Pubertal sequence

A
  1. Accelerated growth
  2. Breast development (thelarche)
  3. Development of pubic and axillary hair (pubarche)
  4. Onset of menstruation (menarche)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Menstrual cycle divided into 2 14 day phases

A

Follicular and luteal which describes the changes in ovary and

Proliferative and secretory phase which describes endometrium over the same period of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The – causes release of fsh from the pituitary gland resulting in development of primary ovarian follicle. The ovarian follicle produces —

A

Follicular phase, ovarian follicle produces estrogen which causes uterine lining to proliferate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

At day 14 there is an – spike in response to preceding estrogen surge which stimulates ovulation, the release of ovum from the follicle

A

Lh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

After ovulation, luteal phase begins. Remnants of the follicle left behind in the ovary develop into corpus luteum. Corpus luteum is responsible for secretion of

A

Progesterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Progesterone

A

Maintains endometrial lining in preparation to receive a fertilized ovum. If fertilization doesn’t occur, corpus luteum degenerates and progesterone levels fall. Without progesterone endometrial lining is sloughed off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

withdrawal of estrogen and progesterone during luteal phase of prior cycle causes gradual increase in FSH. FSH stimulates growth of approx

A

5-15 PRIMORDIAL ovarian follicles, initiating follicular phase again.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

during the follicular phase, the endometrium is in the __ phase

A

proliferative phase, growing in response to estrogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

during the luteal phase, the endometrium is in the __ phase

A

secretory phase., as it matures and is prepared to support the implantation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

if ovum is not fertilized, corpus luteum degenerates after approximately 14 days leading to a fall in __ and __ levels

A

estrogen and progesterone levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

withdrawal of __ causes endometrium to slough, initiating menstrual phase

A

progesterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

estradiol is preserved until late perimenopause when FSH and estradiol both fluctuate

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

define menopause

A

12 months of amenorrhea after final menstrual period in the absence of any other pathological or physiological causes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

early menopause is more common in women with hx of

A
  1. cigarette smoking
  2. short menstrual cycles
  3. nulliparity
  4. type 1 diabetes
  5. family hx of early menopause.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

premature ovarian failure is

A

onset of spontaneous menoapuse before age of 40

17
Q

menopause heralded by menstrual irregularity as # of oocytes capable of responding to FSH and LH decreases and anovulation becomes more frequent. during this period, FSH and LH rise because of diminished estrogen production. the fall in __ levels leads to hot flashes, mood changes, insomnia, depression, osteoporosis and vaginal atrophy

A

estradiol.

18
Q

no gonadal estrogen affects

A

bone (oesteoporosis)
cardiovascular system (atherosclerosis)
uterus/vagina (atrophy)
breast (atrophy)

19
Q

cardiovascular consequence of estrogen decrease:

A

protective benefits of estrogen on lipid profile HDL and decreased LDL and on vascular endothelium
(prevents atherogenesis, increases vasodilation, and inhibits platelet adherence, are lost). women are at increased risk for coronary artery disease.

20
Q

bone resorption accelerates with menopause because

A

estrogen plays important role in regulating osteoclast activity. increased bone resorption can lead to osteopenia and potentially osteoporosis. pts are at increased risk of hip and vertebral fractures, pain, loss of height, and immobility

21
Q

HRT: use of combination of estrogen and progesterone to treat menopausal related sx in women who still have uterus in situ. menopausal sx are due to decrease in ___.

A

estrogen levels.

22
Q

unopposed estrogen exposure whether endogenous or exogenous can result in endometrial hyperplasia and/or endometrial cancer.

A

true

23
Q

when estrogens are being used, with uterus, __ must be used to decrease risk of endometrial hyperplasia and cancer.

A

progestin

24
Q

benefits of HRT and ERT

A

control of menopausal symptoms including reduction of vasomotor flushing , improvement in mood and sleep dysfunction, prevention of urogenital and vaginal atrophy, and improvementin skin and muscle tone. HRT also resulted in decreased risk of colorectal cancer, and both HRT and ERT provided protection from oesteoporotic fractures in hip and vertebra. cardioprotective? no clear data

25
Q

RISKs:

A

increased coronary artery events, increased DVT and PEs, and increased risk of invasive breast cancer who used HRT for prolonged period of time >5 years.

26
Q

contraindications to HRT

A

chronic liver impairment, pregnancy, known estrogen dependent neoplasm (breast, ovary uterus). hx of thromboembolic disease(DVT, PE, CVA). and undiagnosed vaginal bleeding.

27
Q

NON hormonal treatment of menopausal symptoms:

A

should be targed towards individual’s symptoms and treatment goals:
vasomotor symptoms - clonidine (Catapres), SSRI inhibiros such as paroxetine (Paxil) and serotonin and norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine (Effexor).

complementary and alternative therapies - soy, blackcohosh, phytoestrogens, dong quai, evening primrose oil. have not been found to be more effective than placebos.

28
Q

Vaginal and urogenital atrophy can be managed

A

low dose vaginal estrogen. minimal systemic absorption. when used at low vaginal dosing, these estrogen sources do not require opposing progestin use in women with an intact uterus.

29
Q

prevention and treatment for osteoporosis:

A

calcium and vitamin d supplementation; reduction in smoking and caffeine; and alcohol.